Pandemic influenza vaccine (H5N1, whole virion, inactivated, adsorbed, GlaxoSmithKline)

大流行性流感疫苗

Report date: 2025/02/10 20:00:43

Base Information

Drug NamePandemic influenza vaccine (H5N1, whole virion, inactivated, adsorbed, GlaxoSmithKline)
Drug Alias NamePre-pandemic mock-up vaccine (Daronrix)-GlaxoSmithKlinePandemic influenza vaccine (whole virion, inactivated, adjuvanted)Daronrix
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Inactivated vaccine > Whole microorganism inactivated vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsRespiratory Syncytial Virus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited KingdomFrance +[5] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesGlaxosmithkline Plc
Inactive CompaniesN/A
Active IndicationsRespiratory Syncytial Virus Infections
Inactive IndicationsN/A

Other Information

ATC CodeJ07BB01
Related LinksWikipedia